Ambry delivers high-quality, accessible genetic testing for hereditary cancer and exome sequencing for rare disease. A trusted lab for 25 years.

3 days ago · Ambry Genetics will continue operations as a wholly-owned subsidiary of Tempus under its current leadership team. About Tempus. Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating ...

3 days ago · Ambry Genetics will continue operations as a wholly-owned subsidiary of Tempus under its current leadership team. About Tempus Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating ...

3 days ago · Tempus Completes Acquisition of Ambry Genetics. Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it ...

2 days ago · Financing was provided by Ares Management Credit funds. Ambry Genetics will continue operations as a wholly-owned subsidiary of Tempus under its current leadership team. About Tempus.

Discover why Ambry Genetics can help you provide more accurate results for your patients. Learn more today.

Ambry is committed to delivering the most accurate genetic test results possible. Learn more today.

Jan 15, 2025 · The Ambry CARE Program® helps providers identify high-risk patients, offers genetic testing and genetic counseling at scale, and gives patients insights to help them better manage their health. This blog looks at CARE from the patient’s perspective.

2 days ago · Ambry Genetics will continue operations as a wholly-owned subsidiary of Tempus under its current leadership team. About Tempus. Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of multimodal data, and an operating ...

Oct 17, 2024 · Our enhanced menu offers a flexible approach to genetic testing, informed by guidelines and scientific evidence. This comprehensive portfolio will deliver the clinical insights you need, paired with the exceptional support and patient access you have come to …